- Home
- LIPO vs LTRY Comparison
LIPO vs LTRY Comparison
Compare LIPO & LTRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIPO
- LTRY
- Stock Information
- Founded
- LIPO 2005
- LTRY 2015
- Country
- LIPO United States
- LTRY United States
- Employees
- LIPO N/A
- LTRY N/A
- Industry
- LIPO Biotechnology: Pharmaceutical Preparations
- LTRY Computer Software: Prepackaged Software
- Sector
- LIPO Health Care
- LTRY Technology
- Exchange
- LIPO Nasdaq
- LTRY Nasdaq
- Market Cap
- LIPO 3.1M
- LTRY 4.4M
- IPO Year
- LIPO 2022
- LTRY N/A
- Fundamental
- Price
- LIPO $2.27
- LTRY $1.07
- Analyst Decision
- LIPO Strong Buy
- LTRY
- Analyst Count
- LIPO 1
- LTRY 0
- Target Price
- LIPO $16.00
- LTRY N/A
- AVG Volume (30 Days)
- LIPO 2.2M
- LTRY 2.8M
- Earning Date
- LIPO 05-08-2025
- LTRY 04-02-2025
- Dividend Yield
- LIPO N/A
- LTRY N/A
- EPS Growth
- LIPO N/A
- LTRY N/A
- EPS
- LIPO N/A
- LTRY N/A
- Revenue
- LIPO $483,533.00
- LTRY $6,143,350.00
- Revenue This Year
- LIPO N/A
- LTRY N/A
- Revenue Next Year
- LIPO N/A
- LTRY N/A
- P/E Ratio
- LIPO N/A
- LTRY N/A
- Revenue Growth
- LIPO 0.78
- LTRY 190.77
- 52 Week Low
- LIPO $2.02
- LTRY $0.22
- 52 Week High
- LIPO $12.00
- LTRY $2.67
- Technical
- Relative Strength Index (RSI)
- LIPO 36.24
- LTRY 48.11
- Support Level
- LIPO $2.02
- LTRY $1.05
- Resistance Level
- LIPO $3.00
- LTRY $1.28
- Average True Range (ATR)
- LIPO 0.28
- LTRY 0.22
- MACD
- LIPO -0.13
- LTRY -0.07
- Stochastic Oscillator
- LIPO 8.78
- LTRY 11.32
About LIPO Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.
About LTRY Lottery.com Inc.
Lottery.com Inc is a leading provider of domestic and international lottery products and services. As an independent third-party lottery game service, the Company offers a platform that it developed and operates to enable the remote purchase of legally sanctioned lottery games in the U.S. and abroad. The Company's revenue-generating activities are focused on (i) offering the Platform via the Lottery.com app and its websites to users located in the U.S. and international jurisdictions where the sale of lottery games is legal and its services are enabled for the remote purchase of legally sanctioned lottery games; (ii) offering an internally developed, created and operated business-to-business application programming interface of the Platform to enable commercial partners in permitted U.S.